Venus Remedies Share Price
(VENUSREM)
Check the latest share price of Venus Remedies, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹311.55
as on 04:01PM, 29 Apr 2025
NSE
Venus Remedies Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹310.85Day's Price Range₹320.752 Week's Low
52 Week's High
₹270.2552-Week Price Range₹427.9
| Returns % | |
| 1 Month Return | + 6.94 % |
| 3 Month Return | + 3.68 % |
| 1 Year Return | -4.81 % |
| Market Stats | |
| Previous Close | ₹313.20 |
| Open | ₹313.25 |
| Volume | 20.02K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹408.83Cr |
Venus Remedies Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹408.83 Cr
Return on Equity (ROE)
11.53
Return on capital employed (ROCE)
9.39
P/B Ratio
0.8
EPS (TTM)
30.47
Sector
Pharmaceuticals
How to invest in Venus Remedies
Investing in Venus Remedies is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Venus Remedies or VENUSREM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Venus Remedies or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Venus Remedies with just a few clicks!
Venus Remedies Valuation
Track how the P/E of Venus Remedies has moved over time to understand valuation trends.
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (19.96x)
December 15, 2023
Industry (58.33x)
December 15, 2023
Highest (21.65x)
October 6, 2020
Today’s Price to Earnings Ratio: 19.96x
Analysts Recommendation on Venus Remedies
Get updated buy, sell, and hold recommendations by analysts on Venus Remedies.
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Venus Remedies. Average target of ₹307
Source: S&P Global Market Intelligence
Analysts Forecast on Venus Remedies
Get share price movements and forecasts by analysts on Venus Remedies.
Venus Remedies price forecast by 1 analysts
Upside of0.38%
High
₹307
Target
₹307.00
Low
₹307
Venus Remedies target price ₹307, a slight upside of 0.38% compared to current price of ₹311.55. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Venus Remedies revenue growth forecast
Forecast
Actual
Including amortisation and stock based compensations
Venus Remedies EPS growth forecast
Forecast
Actual
Source: S&P Global Market Intelligence
Venus Remedies Financials
Get the annual and quarterly financial summary of Venus Remedies, including revenue, profit, loss and more.
Venus Remedies Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Venus Remedies.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 41.76% | 0.00 | |
| Foreign Institutions | 1% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 57.09% | 0.00 | |
| Others | 0.15% | 0.00 |
Venus Remedies vs Peers
Compare market cap, revenue, PE, and other key metrics of Venus Remedies with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹408.83 Cr | 182.55% | 0.55 | NA | NA | |
| NA | ₹917.81 Cr | 113.16% | 0.55 | NA | NA | |
| NA | ₹81.01 Cr | 41.61% | 0.64 | NA | NA | |
| NA | ₹12.19 Cr | -9.37% | 0.50 | NA | NA | |
| NA | ₹3,197.59 Cr | 34.5% | 0.57 | NA | NA |
Venus Remedies News & Key Events
Latest news and events at one place to help you take investing decisions in Venus Remedies.
Venus Remedies Stock Soars on FDA QIDP Approval - 17 Apr, 2025
Venus Remedies received QIDP designation from the FDA for its investigational antibiotic VRP-034, leading to a significant 14% stock surge, reaching an 8-week high.Venus Remedies Ensures SEBI Compliance - 11 Apr, 2025
Venus Remedies Limited has submitted a compliance certificate confirming proper processing of securities for dematerialisation for the quarter ending March 31, 2025, ensuring regulatory adherence and transparency.
Insights on Venus Remedies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 1.11% to 1.34% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 110.2 Cr → 188.8 Cr (in ₹), with an average increase of 21.9% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 1.22 Cr → 19.6 Cr (in ₹), with an average increase of 73.7% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 55.1%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 127.8%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 57.13% to 56.90% in Mar 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, VENUSREM stock has moved down by -7.1%
About Venus Remedies
Revenue: ₹108.61Cr as on June 2024 (Q2 24)
Net Profit: ₹1.22Cr as on June 2024 (Q2 24)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
| Organisation | Venus Remedies |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Futures and Options
View the latest movement in Venus Remedies Futures & Options, including strike prices, expiry dates, and percentage changes.
FAQs
What is Venus Remedies Ltd price today?
Venus Remedies Ltd share price today stands at ₹311.55, Open: ₹313.25, Previous Close: ₹313.2, High: ₹320.7, Low: ₹310.85, 52 Week High: ₹427.9, 52 Week Low: ₹270.25.
How to Buy Venus Remedies Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Venus Remedies Ltd shares
What are today's traded volumes of Venus Remedies Ltd?
Today's traded volume of Venus Remedies Ltd(VENUSREM) is 20.02K.
What is today's market capitalisation of Venus Remedies Ltd?
Today's market capitalisation of Venus Remedies Ltd(VENUSREM) is ₹408.83 Cr.
What is the 52 Week High and Low Range of Venus Remedies Ltd?
How much percentage Venus Remedies Ltd is down from its 52 Week High?
Venus Remedies Ltd (VENUSREM) share price is ₹311.55. It is down -27.19% from its 52 Week High price of ₹427.9
How much percentage Venus Remedies Ltd is up from its 52 Week low?
Venus Remedies Ltd (VENUSREM) share price is ₹311.55. It is up 15.28% from its 52 Week Low price of ₹270.25